| NCT ID | NCT06672835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Mental Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-10-05 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-10-05 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study tests effects of eBASIS on treatment fidelity and youth outcomes, compared to a digitally delivered control (N=32 clinicians; 96 clients). A well-established EBP (Cognitive Behavioral Therapy Plus), will be a focus of the investigation, which eligible participants will already be signed up to receive.
Eligibility Criteria
Inclusion Criteria: * Mental health provider who spends 2 hours or more providing supports in school setting * Registered to receive CBT+ training from the WA State EBP Initiative Exclusion Criteria: * None
Contact & Investigator
Aaron Lyon, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT06672835 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06672835 currently recruiting?
Yes, NCT06672835 is actively recruiting participants. Contact the research team at lyona@uw.edu for enrollment information.
Where is the NCT06672835 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06672835 clinical trial?
NCT06672835 is sponsored by University of Washington. The principal investigator is Aaron Lyon, PhD at University of Washington. The trial plans to enroll 32 participants.